Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism MUC13 inhibitors(mucin 13, cell surface associated inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Theragen Bio Co., Ltd.Startup |
Active Organization Theragen Bio Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rectal Cancer | Preclinical | KR | Theragen Bio Co., Ltd.Startup | 14 May 2024 |